Sub-cutaneous Infliximab in Inflammatory Rheumatic Disease

NCT05424926 · clinicaltrials.gov ↗
COMPLETED
Status
22
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators